Table 3 Primary and secondary outcomes.
Variable | Control group (n = 41) | TAP + LMA group (n = 42) | P-value |
|---|---|---|---|
Postoperative time of readiness for discharge (days) | 8 (5–13) | 7 (5–11) | 0.004 |
Postoperative apioid (sufentanil) requirement within 48 h (µg) | 135.7 ± 20.1 | 102.8 ± 12.4 | 0.000 |
NRS pain score | |||
2 h after surgery | 4.2 ± 1.4 | 3.3 ± 1.1 | 0.001 |
6 h after surgery | 4.8 ± 1.4 | 3.8 ± 1.1 | 0.001 |
24 h after surgery | 3.8 ± 1.1 | 3.1 ± 1.2 | 0.007 |
48 h after surgery | 3.0 ± 1.1 | 2.3 ± 0.9 | 0.001 |
First mobilization off the bed (h) | 43.8 ± 5.1 | 28.1 ± 5.5 | 0.000 |
Time to first flatus (h) | 47.2 ± 7.6 | 32.7 ± 5.8 | 0.000 |
QoR-40 score | |||
1 day before surgery | 194.5 ± 3.3 | 193.8 ± 3.1 | 0.323 |
1 day after surgery | 169.5 ± 6.1 | 179.0 ± 5.6 | 0.000 |
3 days after surgery | 176.0 ± 5.1 | 187.8 ± 5.1 | 0.000 |
Day of discharge | 192.0 ± 5.0 | 193.6 ± 4.2 | 0.113 |
Incidence of nausea/vomiting within 48 h | |||
Nausea | 6 | 4 | 0.475 |
Vomiting | 3 | 1 | 0.294 |
Total cost for treatment (CNY) | 84,434.0 ± 9,436.2 | 66,608.4 ± 6,268.4 | 0.000 |
